Literature DB >> 8916957

Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase.

K Izuhara1, R A Feldman, P Greer, N Harada.   

Abstract

We have previously demonstrated that interleukin-4 (IL-4) induces tyrosine phosphorylation of a protein closely related or identical to the c-fes proto-oncogene product (FES) and association of this protein with the IL-4 receptor alpha chain (IL-4R alpha). IL-4 is known to induce association of phosphatidylinositol-3 (PI3) kinase with the IL-4R alpha. Since FES contains the consensus motifs for PI3 kinase binding, we tested the possibility that FES may associate with PI3 kinase upon IL-4 stimulation. We demonstrate herein that IL-4 stimulation induced rapid association of FES or a related protein with PI3 kinase in mouse T-cell lines. We also show an association of human FES (hFES) with the src homology 2 (SH2) domain of PI3 kinase in a COS7 cell expression system. The in vitro PI3 kinase assay using COS7 cells suggested that hFES partly contributes to the association between the hIL-4R alpha and PI3 kinase. We have further identified the important region in the cytoplasmic domain of the hIL-4R alpha for association of tyrosine-phosphorylated hFES with the hIL-4R alpha and SH2 domain of PI3 kinase using a COS7 cell expression system. These results suggest that FES or a related protein/PI3 kinase pathway may play a role in the pleiotropic effects of IL-4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916957

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Enhanced endotoxin sensitivity in fps/fes-null mice with minimal defects in hematopoietic homeostasis.

Authors:  Ralph A Zirngibl; Yotis Senis; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

2.  A point mutation in the N-terminal coiled-coil domain releases c-Fes tyrosine kinase activity and survival signaling in myeloid leukemia cells.

Authors:  H Y Cheng; A P Schiavone; T E Smithgall
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

3.  Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.

Authors:  Shengnan Zhang; Violeta Chitu; E Richard Stanley; Bruce E Elliott; Peter A Greer
Journal:  Cancer Res       Date:  2010-12-15       Impact factor: 12.701

4.  IL-4 up-regulates cyclooxygenase-1 expression in macrophages.

Authors:  Ashley E Shay; Bastihalli T Diwakar; Bo-Jhih Guan; Vivek Narayan; Joseph F Urban; K Sandeep Prabhu
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

5.  Phospholipase D2 (PLD2) shortens the time required for myeloid leukemic cell differentiation: mechanism of action.

Authors:  Mauricio Di Fulvio; Kathleen Frondorf; Karen M Henkels; William C Grunwald; David Cool; Julian Gomez-Cambronero
Journal:  J Biol Chem       Date:  2011-11-17       Impact factor: 5.157

6.  Phase I pharmacokinetic and pharmacodynamic study of the pan-PI3K/mTORC vascular targeted pro-drug SF1126 in patients with advanced solid tumours and B-cell malignancies.

Authors:  D Mahadevan; E G Chiorean; W B Harris; D D Von Hoff; A Stejskal-Barnett; W Qi; S P Anthony; A E Younger; D M Rensvold; F Cordova; C F Shelton; M D Becker; J R Garlich; D L Durden; R K Ramanathan
Journal:  Eur J Cancer       Date:  2012-08-23       Impact factor: 9.162

7.  Pathological significance and prognostic significance of FES expression in bladder cancer vary according to tumor grade.

Authors:  Akihiro Asai; Yasuyoshi Miyata; Kosuke Takehara; Shigeru Kanda; Shin-Ichi Watanabe; Peter A Greer; Hideki Sakai
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-26       Impact factor: 4.553

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.